Norman H Pessin has bought stock on 4 days since Jul 2017
10% owner at Precision Optics Corporation, Inc., and 3 other companies
SEC CIK 0000923666 · Filings on SEC.gov ↗
Norman H Pessin's record
3 months after each buy, from the first price a copier could get.
No buys have 3 months of prices yet. A record shows here at 3.
Companies
Every filing
6 filings since Jul 2017, newest first
Precision Optics Corporation, Inc.
10% owner
Duos Technologies Group, Inc.
10% owner
Duos Technologies Group, Inc.
10% owner
Ictv Brands Inc.
Insider
Ictv Brands Inc.
Insider
Immucell Corp /de/
Insider
About Norman H Pessin
Norman H. Pessin is a private individual and significant shareholder in Precision Optics Corporation, Inc. (NASDAQ: POCI), where he is reported as a 10% owner and corporate insider under U.S. securities regulations.( SEC-related ownership trackers show that Pessin has accumulated a substantial position in Precision Optics through multiple purchases, including notable acquisitions reported on Form 4 and Schedule 13D/13D‑A filings.( As of recent filings, he has been disclosed as holding hundreds of thousands of Precision Optics shares and at times exceeding the 5% beneficial ownership threshold, triggering major shareholder reporting obligations.( His insider status derives from his role as a large, active investor rather than as an officer or director of the company.(
Beyond Precision Optics, Norman H. Pessin is an established professional investor with significant positions in several small‑cap and micro‑cap public companies, including Duos Technologies Group Inc., ImmuCell Corp, LiqTech International Inc, Chembio Diagnostics Inc, and ICTV Brands Inc, among others.( Ownership data compiled from SEC filings indicates that he has held concentrated stakes—such as 650,000 shares of ImmuCell Corp and sizeable positions in Duos Technologies and Precision Optics—suggesting a specialized focus on emerging and niche technology and healthcare businesses.( Public sources do not provide verified details on his formal education or early career, but his repeated Schedule 13D and Form 4 filings over many years reflect a long‑standing career as a sophisticated, SEC‑reporting investor in U.S. public markets.(
Written by Perplexity from public sources.
Filings come from SEC EDGAR. Not investment advice.